Development of a Novel Cyclodextrin-Chitosan Polymer for an Efficient Removal of Pharmaceutical Contaminants in Aqueous Solution.

adsorption chitosan cyclodextrin polymer ibuprofen pharmaceutical residue progesterone

Journal

Materials (Basel, Switzerland)
ISSN: 1996-1944
Titre abrégé: Materials (Basel)
Pays: Switzerland
ID NLM: 101555929

Informations de publication

Date de publication:
21 Jul 2024
Historique:
received: 14 05 2024
revised: 17 07 2024
accepted: 19 07 2024
medline: 27 7 2024
pubmed: 27 7 2024
entrez: 27 7 2024
Statut: epublish

Résumé

A novel polymer synthesized by grafting three cyclodextrins onto chitosan was characterized and evaluated for its potential to adsorb two pharmaceutical residues: ibuprofen and progesterone. The influence of various operational parameters, including contact time, initial molecule concentration, pH, ionic strength, and temperature, was investigated. The synthesized polymer exhibits an amorphous and porous structure with a remarkable swelling capacity of 9.5 mmol/g. It demonstrates remarkable adsorption capacities for progesterone and ibuprofen, reaching 90% and 75%, respectively. Kinetic studies reveal that the adsorption of both molecules follows a pseudo-second-order model. A DSC analysis elucidated the adsorption mechanism, which is governed by the formation of inclusion complexes and electrostatic interactions within the polymer network. The polymer's regeneration after 23 cycles demonstrates its sustainable adsorption efficiency. The combination of chitosan with three cyclodextrins opens up promising new avenues for water treatment and the removal of specific pollutants. This approach significantly improves the material's selectivity towards target pollutants, offering a significant advantage in pollution remediation applications.

Identifiants

pubmed: 39063886
pii: ma17143594
doi: 10.3390/ma17143594
pii:
doi:

Types de publication

Journal Article

Langues

eng

Auteurs

Fadila Oughlis-Hammache (F)

UNIROUEN, Galenic Pharmaceutical Laboratory, NorDIC Inserm U1239, UFR Medicine and Pharmacy, Rouen University, Normandie Univ, 22 Bd Gambetta, F-76183 Rouen, France.
Laboratory of Membrane Processes and of Separation and Recovery Techniques, Faculty of Technology, Abderrahmane Mira University, Route de Targua Ouzemmour, Bejaia 06000, Algeria.
Faculty of Science and Applied Sciences, Department of Process Engineering, Akli Mohand Oulhadj University, Bouira 10000, Algeria.

Mohamed Skiba (M)

UNIROUEN, Galenic Pharmaceutical Laboratory, NorDIC Inserm U1239, UFR Medicine and Pharmacy, Rouen University, Normandie Univ, 22 Bd Gambetta, F-76183 Rouen, France.

Lamia Moulahcene (L)

UNIROUEN, Galenic Pharmaceutical Laboratory, NorDIC Inserm U1239, UFR Medicine and Pharmacy, Rouen University, Normandie Univ, 22 Bd Gambetta, F-76183 Rouen, France.
Laboratory of Membrane Processes and of Separation and Recovery Techniques, Faculty of Technology, Abderrahmane Mira University, Route de Targua Ouzemmour, Bejaia 06000, Algeria.
Institute of Technology, Department of Process Engineering, Akli Mohand Oulhadj University, Bouira 10000, Algeria.

Nicolas Milon (N)

UNIROUEN, Galenic Pharmaceutical Laboratory, NorDIC Inserm U1239, UFR Medicine and Pharmacy, Rouen University, Normandie Univ, 22 Bd Gambetta, F-76183 Rouen, France.

Frédéric Bounoure (F)

UNIROUEN, Galenic Pharmaceutical Laboratory, NorDIC Inserm U1239, UFR Medicine and Pharmacy, Rouen University, Normandie Univ, 22 Bd Gambetta, F-76183 Rouen, France.

Malika Lahiani-Skiba (M)

UNIROUEN, Galenic Pharmaceutical Laboratory, NorDIC Inserm U1239, UFR Medicine and Pharmacy, Rouen University, Normandie Univ, 22 Bd Gambetta, F-76183 Rouen, France.

Classifications MeSH